ARB Superiority Over ACE Inhibitors in Coronary Heart Disease: An Alternative Viewpoint

Pharmacotherapy. 2019 Feb;39(2):204-206. doi: 10.1002/phar.2216. Epub 2019 Feb 4.

Authors

Steven M Smith^{1

2}, Jimin Lee³, Sukhyang Lee³

Affiliations

¹ Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida.
² Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, Florida.
³ College of Pharmacy, Ajou University, Suwon, South Korea.

No abstract available

Keywords: ACE inhibitors; angiotensin receptor blocker; coronary heart disease; epidemiology; study design.

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Cohort Studies
Coronary Disease*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding

K01 HL138172/HL/NHLBI NIH HHS/United States